The miR‐3127‐5p/p‐<scp>STAT</scp>3 axis up‐regulates <scp>PD</scp>‐L1 inducing chemoresistance in non‐small‐cell lung cancerDongfang Tang(Hunan Normal University), Yifeng Sun(Shanghai Pulmonary Hospital)Journal of Cellular and Molecular MedicineMay 4, 201810.1111/jcmm.13657Cited by 76SaveCiteExport RISWatch citationsRelated PapersReduced miR-3127-5p expression promotes NSCLC proliferation/invasion and contributes to dasatinib sensitivity via the c-Abl/Ras/ERK pathway|Scientific Reports|2014|35Neoadjuvant camrelizumab (an anti-PD-1 antibody) plus chemotherapy or apatinib (a VEGFR-2 inhibitor) for initially unresectable stage II–III non-small-cell lung cancer: a multicentre, two-arm, phase 2 exploratory study|Signal Transduction and Targeted Therapy|2024|30